EC Number | Application | Comment | Organism |
---|---|---|---|
1.3.1.9 | medicine | tuberculosis, TB, target of anti-tubercular agents | Mycobacterium tuberculosis |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.3.1.9 | into a pET15b vector for expression in Escherichia coli BL21-Gold (DE3) | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.9 | 1-cyclohexyl-N-(3,5-diphenyl-4-hydroxyl)phenyl-5-oxopyrrolidine-3-carboxamide | best inhibitor of the sreening with an IC50: 62 nanoM | Mycobacterium tuberculosis | |
1.3.1.9 | pyrrolidine carboxamide | IC50: 10.05 microM, chosen as a lead structure for further structure optimization | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.9 | acyl-[acyl-carrier protein] + NAD+ | Mycobacterium tuberculosis | - |
trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+ | - |
? | |
1.3.1.9 | acyl-[acyl-carrier protein] + NAD+ | Mycobacterium tuberculosis H37Rv | - |
trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.3.1.9 | Mycobacterium tuberculosis | P9WGR1 | - |
- |
1.3.1.9 | Mycobacterium tuberculosis H37Rv | P9WGR1 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.3.1.9 | using a 15Q high-resolution anion exchange column and a Hightrap butyl Sepharose column | Mycobacterium tuberculosis |
EC Number | Storage Stability | Organism |
---|---|---|
1.3.1.9 | -20°C, 30 mM PIPES, pH 6.8, 50% glycerol, 6 months | Mycobacterium tuberculosis |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.9 | acyl-[acyl-carrier protein] + NAD+ | - |
Mycobacterium tuberculosis | trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+ | - |
? | |
1.3.1.9 | acyl-[acyl-carrier protein] + NAD+ | - |
Mycobacterium tuberculosis H37Rv | trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.3.1.9 | enoyl acyl carrier protein reductase | - |
Mycobacterium tuberculosis |
1.3.1.9 | enoyl-[acyl-carrier-protein] reductase | - |
Mycobacterium tuberculosis |
1.3.1.9 | ENR | - |
Mycobacterium tuberculosis |
1.3.1.9 | InhA | - |
Mycobacterium tuberculosis |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.3.1.9 | 23 | - |
activity assay | Mycobacterium tuberculosis |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.3.1.9 | 6.8 | - |
activity assay | Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.9 | NADH | - |
Mycobacterium tuberculosis |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.3.1.9 | 0.000062 | - |
best inhibitor of the sreening with an IC50: 62 nanoM | Mycobacterium tuberculosis | 1-cyclohexyl-N-(3,5-diphenyl-4-hydroxyl)phenyl-5-oxopyrrolidine-3-carboxamide | |
1.3.1.9 | 0.01005 | - |
IC50: 10.05 microM, chosen as a lead structure for further structure optimization | Mycobacterium tuberculosis | pyrrolidine carboxamide |